Powell signaled the cuts might be finished for the year
When the world's most powerful central bank speaks, even distant markets pause to listen. The Federal Reserve's decision to cut rates by a quarter point on Wednesday offered little comfort once Chair Jerome Powell suggested the easing cycle may be nearing its end — a signal that sent Indian equities lower on Thursday, with the Sensex shedding nearly 600 points and the Nifty50 slipping below 25,900. In the larger human story of capital and confidence, this is a familiar moment: relief at what was given, unease about what may not come next.
- The Fed's hawkish undertone — not the rate cut itself, but Powell's warning that December relief is far from guaranteed — triggered a broad reassessment of risk across global markets.
- Indian benchmarks bore the weight of that reassessment, with the Sensex falling 593 points and the Nifty50 closing at 25,877, as pharmaceutical heavyweights like Dr. Reddy's and Cipla led sectoral declines.
- Asian markets offered no shelter, with Tokyo's Nikkei slipping and Australia's ASX 200 retreating, even as Japan's Kospi managed a modest gain — a patchwork of caution rather than consensus.
- Wall Street's own internal conflict was telling: the Dow touched an all-time high before retreating, while the Nasdaq climbed to a record on tech strength — a market still negotiating its own direction.
- Investors now look beyond monetary policy to geopolitics, with a potential Trump-Xi meeting and U.S.-China trade talks poised to become the next variable shaping sentiment in the sessions ahead.
Indian stock markets arrived at Thursday's session already on guard, and by the close, that wariness had crystallized into a meaningful selloff. The BSE Sensex shed 592.67 points to finish at 84,404.46, while the NSE Nifty50 dropped 176 points to 25,877.75. The source of the pressure was unmistakable: the Federal Reserve had delivered the expected quarter-point rate cut, but Fed Chair Jerome Powell's accompanying remarks unsettled investors far more than the cut itself reassured them. His suggestion that a December follow-up was far from certain effectively told markets that the easing cycle might already be over.
The reverberations spread across Asia. Japan's Nikkei slipped while the Kospi edged higher, and Australia's ASX 200 fell modestly — a continent of mixed signals united by a single underlying anxiety about where monetary policy goes from here. Back in India, mid- and small-cap indices barely moved, while pharmaceutical stocks absorbed disproportionate losses, with Dr. Reddy's falling 4% and Cipla dropping 3%, suggesting investors were unwinding defensive positions in anticipation of a prolonged higher-rate environment.
Across the Pacific, Wall Street offered its own contradictions. The Dow touched a record intraday before closing lower, while the Nasdaq climbed to an all-time high of 23,958.47, carried by technology names including Nvidia. The divergence captured a market that has not yet settled on a coherent narrative. For Indian investors, the immediate response was to sell and wait — for clarity on the Fed's next move, and for the outcome of a looming Trump-Xi meeting that could redraw the contours of global trade.
Indian stock markets opened Thursday morning already bracing for disappointment. By the closing bell, that caution had turned into a sharp selloff. The BSE Sensex dropped 592.67 points—a 0.70% decline that landed it at 84,404.46. The NSE Nifty50 fell 176.05 points, or 0.68%, closing at 25,877.75. The culprit was not hard to identify: the Federal Reserve had cut interest rates by a quarter point as expected, but then delivered a message that spooked markets worldwide. Fed Chair Jerome Powell made clear that another rate cut in December was far from certain, effectively signaling that the central bank's easing cycle might be finished for the year.
This shift in tone rippled across Asia. Markets there opened mixed, caught between relief at the rate cut itself and unease about what comes next. Japan's Kospi managed a small gain of 0.94%, but Tokyo's Nikkei slipped 0.25% while the Topix edged up 0.33%. Australia's ASX 200 fell 0.2%. The message was consistent: investors were recalibrating their expectations for monetary policy, and that recalibration was pushing money away from riskier assets.
In the broader Indian market, the picture was similarly cautious. The Nifty MidCap 100 inched up just 0.1%, while the Nifty SmallCap 100 dipped 0.1%—movements so small they barely registered as movement at all. Pharmaceutical stocks took a particular hit, with companies like Dr. Reddy's Laboratories falling 4% and Cipla dropping 3%. The sector's weakness suggested that investors were rotating out of defensive positions, anticipating a longer period of higher interest rates ahead.
Wall Street itself remained conflicted. The Dow Jones dipped 0.2% despite touching an all-time high during the trading day, a pattern that captured the market's internal struggle. The S&P 500 ended slightly lower. But the Nasdaq climbed 0.55% to a record 23,958.47, buoyed by gains in technology stocks, particularly Nvidia. That divergence—weakness in traditional sectors, strength in tech—reflected a market still searching for direction.
Underlying all of this was a broader question about what comes next. Investors were watching not just the Fed's next move but also the trajectory of U.S.-China trade relations. A meeting between President Trump and Chinese leader Xi Jinping loomed, their first since Trump's second term began. The outcome of those discussions could reshape trade policy in ways that would ripple through global markets. For now, Indian investors were caught in that uncertainty, selling first and asking questions later.
Notable Quotes
A December rate cut is far from a foregone conclusion— Fed Chair Jerome Powell
The Hearth Conversation Another angle on the story
Why did the Fed's rate cut actually make markets worse instead of better?
Because Powell essentially said this might be the last cut. A rate cut is good news in isolation, but only if investors believe more cuts are coming. When the Fed signals the cuts are over, it means interest rates will stay higher for longer, which makes bonds more attractive and stocks less so.
So investors are already pricing in a scenario where rates stay elevated?
Exactly. They're repositioning now rather than waiting. If you think rates will be stuck at 3.75% for months, you're less likely to hold growth stocks that need a lower-rate environment to justify their valuations.
Why did pharma stocks get hit so hard—down 4% and 3%?
Pharma is often seen as defensive, a place to hide when uncertainty rises. But when the market starts rotating out of defensive positions because it thinks the worst is over, those stocks get sold. It's a signal that investors are becoming more risk-on, not less.
But the Nasdaq hit a record high. Doesn't that contradict the selloff?
Not really. Tech, especially Nvidia, is benefiting from a different narrative—AI growth and productivity gains that don't depend on interest rates the same way. The market is splitting: old economy down, new economy up.
What's the Trump-Xi meeting about in this context?
Trade. If Trump and Xi reach an agreement, tariffs might ease, which would be good for global growth and corporate earnings. If they don't, tariffs could spike, which would hurt growth. Right now, that uncertainty is keeping investors cautious.